A5101568730- Brain Metastases and Treatment
- Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Research Studies
- Gastric Cancer Management and Outcomes
- Management of metastatic bone disease
- Esophageal and GI Pathology
- Healthcare Technology and Patient Monitoring
- Growth Hormone and Insulin-like Growth Factors
- Head and Neck Surgical Oncology
- Metastasis and carcinoma case studies
- Melanoma and MAPK Pathways
- Non-Invasive Vital Sign Monitoring
- Medical Imaging Techniques and Applications
- Pituitary Gland Disorders and Treatments
- Glioma Diagnosis and Treatment
- Esophageal Cancer Research and Treatment
- Radiation Therapy and Dosimetry
- Sarcoma Diagnosis and Treatment
- Advanced Radiotherapy Techniques
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Ferroptosis and cancer prognosis
- Radiomics and Machine Learning in Medical Imaging
First Bethune Hospital of Jilin University
2024
Jilin University
2014-2023
First Hospital of Jilin University
2014-2023
Changchun Obstetrics and Gynecology Hospital
2018
Jilin Province Tumor Hospital
2016
First Affiliated Hospital of Xinjiang Medical University
2015
Xinjiang Medical University
2015
The University of Texas MD Anderson Cancer Center
2005
Concurrent chemoradiotherapy (CCRT) is the standard treatment for locally advanced esophageal squamous cell carcinoma (ESCC). However, optimal radiotherapy regimen, particularly in terms of total dose and planned range irradiation field, remains unclear. This phase III clinical trial aimed to compare survival benefits between different radiation doses target fields.
BACKGROUND: Although the information on validation status of electronic sphygmomanometer (ES) devices in use health care institutions and households is much more clinically relevant than that ES models available market, it remains insufficient. METHODS: A national survey was conducted across all administrative regions mainland China to assess ESs. Fifty-eight cities were selected with stratification by municipality, provincial capital, other cities, each city chosen convenience identify...
Chemo-radiotherapy (CRT) remains the main treatment modality for non-small-cell lung cancer (NSCLC). However, its clinical efficacy is largely limited by individual variations in radio-sensitivity and radiotherapy-associated toxicity. There an urgent need to identify genetic determinants that can explain patients' likelihood develop recurrence toxicity following CRT. In this study, we performed comprehensive genomic profiling, using a 474-cancer- radiotherapy-related gene panel, on...
We investigated type II deiodinase (DIO 2 ) polymorphisms and serum thyroid hormone levels in subjects with mild cognitive impairment (MCI) a Uygur population.We studied the DIO Thr92Ala (rs225014) ORFa-Gly3Asp (rs12885300) of 129 unrelated MCI cases 131 matched controls.All were genotyped using SNaPshot SNP genotyping assays.Serum measured by radioimmunoassay.Levels triiodothyronine thyroxine group significantly lower than those control group.Genotype allele frequencies gene between groups...
Background: In outcome studies of oncology patients undergoing radiation, researchers extract valuable information from medical records generated before, during, and after radiotherapy visits, such as survival data, toxicities, complications. Clinical rely heavily on these data to correlate the treatment regimen with prognosis develop evidence-based radiation therapy paradigms. These are available mainly in forms narrative texts or table formats heterogeneous vocabularies. Manual extraction...
A 54-year-old woman presented with left axillary adenopathy for 6 months. Biopsy result was consistent nodal metastases of breast carcinoma: estrogen receptor (negative), progesterone and Her-2 (negative). The primary tumor, however, could not be detected on ultrasound, mammography, magnetic resonance imaging. F-FDG PET/CT revealed a mildly FDG-avid nodule in her breast, tumor. She received neoadjuvant chemotherapy followed by modified radical mastectomy. case demonstrates the usefulness FDG...
Leptomeningeal metastasis, which results from metastasis of tumors to the arachnoid and pia mater, can lead dissemination tumor cells throughout subarachnoid space via cerebral spinal fluid, frequently with a poor prognosis. The primary in adults is most often breast cancer, lung or melanoma. Although leptomeningeal due cholangiocarcinoma has been reported, best our knowledge there no cytologically confirmed report hepatocellular carcinoma. We herein case carcinoma 53-year-old woman...
To determine toxicities, maximally tolerated dose (MTD), and potential antitumor activity of intrathecal pemetrexed (IP). MATERIAL AND Pulmonary adenocarcinoma patients with recurrent or progressive leptomeningeal metastases (LM) after chemotherapy other LM-related therapy were included. IP doses escalated from 10 mg to 15 mg, even 20 mg. Protocol schema was twice per week for 2 weeks (induction therapy), followed by once 2–4 (consolidation therapy). The primary endpoints MTD safety....
Purpose: To determine whether the dose perturbations caused by implanted markers in or near mobile tumors have significant impact on distributions, particularly creating hot cold spots behind markers. Method and Materials: A preliminary dose-depth distribution measurement with 200 MeV protons has been performed at Proton Medical Research Center of University Tsukuba. The effective-source size was approximately 4 cm, source-to-surface distance (SSD) 250 cm Spread Out Bragg Peak (SOBP)...